Measles cases in Texas and New Mexico rose to 351 on Friday, the health departments of the states said, an increase of 34 ...

The CDC's vaccine advisory meeting initially scheduled for February has been rescheduled to April 15-16 to allow public ...

U.S. News & World Report: Calling The Shots: Tracking Robert F. Kennedy Jr.'s Moves On Vaccines Since taking the helm of HHS, Robert F. Kennedy Jr. has both backed vaccination as a public health ...

AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker ...

AstraZeneca (AZN) stock in focus as the company invests $2.5B in Beijing for a new R&D center, strengthening its footprint in ...

The $2.5 billion investment reflects AstraZeneca's continued commitment to China, Chief Executive Pascal Soriot said. The R&D facility will be the company's second in China, coming after its research ...

British pharmaceutical giant AstraZeneca announced on Friday that it will invest $2.5 billion in a research and development ...

Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical ...

Government borrowing hit £132.2bn overall in the financial year, while a fire near Heathrow disrupted global flights.

Last November, results from the MITIGATE trial made headlines at ACR Convergence 2024 with positive phase 3 trial data for inebilizumab, an IgG1 monoclonal antibody targeting CD19, in patients with ...